Phase
Condition
N/ATreatment
Collagen hydrolysate
Placebo
Clinical Study ID
Ages 18-70 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Main Inclusion Criteria:
Prediabetic subjects: Male and female subjects with prediabetic HbA1c values between 5.7% and 6.4% and/or fasting glucose ≥ 100 mg/dL and ≤ 125 mg/dL (in venous plasma) (twice confirmed at two independent days if HbA1c is < 5.7%) or Healthynormo-glycaemic subjects: fasting glucose <100 mg/dL and HbA1c is < 5.7%
Age: 18-70 years
Body mass index 19-35 kg/m2
Current Non-smoker
Signed informed consent form
No changes in food habits or physical activity 3 months prior to screening andduring the study
If applicable, stable intake of chronic medication of at least 4 weeks
Exclusion
Main Exclusion Criteria:
Subjects with diagnosed Type 2 Diabetes mellitus with medical treatment
Presence of disease or drug(s) influencing digestion (incl. recent intake ofantibiotics) and absorption of nutrients
Intake of medications known to affect glucose tolerance, e.g., diabetic medication,SGLT-2 inhibitors, GLP-1 receptor agonists, steroids, protease inhibitors orantipsychotics
Chronic intake of substances affecting blood coagulation (e.g. acetylic acid (100 mgas standard prophylactic treatment allowed when dose is stable 1 month prior toscreening), anticoagulants, diuretics, thiazides (diuretics and thiazides allowede.g. for hypertension treatment when dose is stable 1 month prior to screening)),which in the Investigator's opinion would impact patient safety
Severe liver or renal disease or laboratory evidence of hepatic dysfunction (i.e.alkaline phosphatase, ALT, AST >3 x ULN)
Known inflammatory or malignant gastrointestinal diseases (i.e. colitis ulcerosa,Morbus Crohn, celiac disease, malignant diseases e.g. colon-cancer, rectum cancer,pancreatitis)
Clinically relevant findings as established by medical history, physicalexamination, clinical laboratory and/or vital signs
Intake of food supplements known to affect glucose tolerance, e.g., cinnamoncapsules, conjugated linoleic acids
Drug-, alcohol- and medication abuses
Pregnant or breast-feeding women
Study Design
Connect with a study center
BioTeSys GmbH
Esslingen, 73728
GermanySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.